A new versatile peptide-based size exclusion chromatography platform for global profiling and quantitation of candidate biomarkers in hepatocellular carcinoma specimens

Proteomics

Volumn 11, Issue 10, 2011, Pages 1976-1984

  Lee, Hyoung Joo ^a   Na, Keun ^a   Kwon, Min Seok ^b   Park, Taesung ^b   Kim, Kyung Sik ^c   Kim, Hoguen ^c   Paik, Young Ki ^a  

^a Yonsei University   (South Korea)

^b Seoul National University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Disease biomarker; HCC; N linked glycopeptides; Quantitation; SEC; Technology

Indexed keywords

BIOLOGICAL MARKER; CARBOXYLESTERASE; GLYCOPEPTIDE; INSULIN RECEPTOR SUBSTRATE 2; PEPTIDE; PROTEOME;

ANALYTIC METHOD; ARTICLE; CANCER TISSUE; CONTROLLED STUDY; DISEASE MARKER; FRACTIONATION; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REPRODUCIBILITY;

AMINO ACID SEQUENCE; CARCINOMA, HEPATOCELLULAR; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, LIQUID; GLYCOPEPTIDES; HUMANS; LIVER; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PEPTIDE FRAGMENTS; PEPTIDE MAPPING; PROTEOMICS; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 79955770749     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100002     Document Type: Article

References (31)

1. Paik, Y. K., Kim, H., Lee, E. Y., Kwon, M. S., Cho, S. Y., Overview and introduction to clinical proteomics. Methods Mol. Biol. 2008, 428, 1-31.
2. Ludwig, J. A., Weinstein, J. N., Biomarkers in cancer staging, prognosis and treatment selection. Nat. Rev. Cancer 2005, 5, 845-856.
3. Lee, H. J., Lee, E. Y., Kwon, M. S., Paik, Y. K., Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics. Curr. Opin. Chem. Biol. 2006, 10, 42-49.
4. McIntosh, M., Fitzgibbon, M., Biomarker validation by targeted mass spectrometry. Nat. Biotechnol. 2009, 27, 622-623.
5. Delahunty, C., Yates, J. R., Protein identification using 2D-LC-MS/MS. Methods 2005, 35, 248-255.
6. Hu, L., Ye, M., Zou, H., Recent advances in mass spectrometry-based peptidome analysis. Expert Rev. Proteomics 2009, 6, 433-447.
7. Righetti, P. G., Castagna, A., Herbert, B., Reymond, F., Rossier, J. S., Prefractionation techniques in proteome analysis. Proteomics 2003, 3, 1397-1407.
8. Hörth, P., Miller, C. A., Preckel, T., Wenz, C., Efficient fractionation and improved protein identification by peptide OFFGEL electrophoresis. Mol. Cell. Proteomics 2006, 5, 1968-1974.
9. Kostanski, L. K., Keller, D. M., Hamielec, A. E., Size-exclusion chromatography - a review of calibration methodologies. J. Biochem. Biophys. Methods 2004, 58, 159-186.
10. Morgareidge, K. R., Hammel, H. T., Evaporative water loss in box turtles: effects of rostral brainstem and other temperatures. Science 1975, 187, 366-368.
11. Lecchi, P., Gupte, A. R., Perez, R. E., Stockert, L. V., Abramson, F. P., Size-exclusion chromatography in multidimensional separation schemes for proteome analysis. J. Biochem. Biophys. Methods 2003, 56, 141-152.
12. Opiteck, G. J., Jorgenson, J. W., Two-dimensional SEC/RPLC coupled to mass spectrometry for the analysis of peptides. Anal. Chem. 1997, 69, 2283-2291.
13. Hu, L., Li, X., Jiang, X., Zhou, H. et al., Comprehensive peptidome analysis of mouse livers by size exclusion chromatography prefractionation and nanoLC-MS/MS identification. J Proteome Res. 2007, 6, 801-808.
14. Alvarez-Manilla, G., Atwood, J., 3rd, Guo, Y., Warren, N.L. et al., Tools for glycoproteomic analysis: size exclusion chromatography facilitates identification of tryptic glycopeptides with N-linked glycosylation sites. J. Proteome Res. 2006, 5, 701-708.
15. Bosch, F. X., Ribes, J., Díaz, M., Cléries, R., Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004, 127, S5-S16.
16. Donati, M., Brancato, G., Donati, A., Clinical biomarkers in hepatocellular carcinoma (HCC). Front. Biosci. 2010, 2, 517-571.
17. Park, K. S., Kim, H., Kim, N. G., Cho, S. Y. et al., Proteomic analysis and molecular characterization of tissue ferritin light chain in hepatocellular carcinoma. Hepatology 2002, 35, 1459-1466.
18. Na, K., Lee, E. Y., Lee, H. J., Kim, K. Y. et al., Human plasma carboxylesterase 1, a novel serologic biomarker candidate for hepatocellular carcinoma. Proteomics 2009, 9, 3989-3999.
19. Lee, H. J., Na, K., Choi, E. Y., Kim, K. S. et al., Simple method for quantitative analysis of N-linked glycoproteins in hepatocellular carcinoma specimens. J. Proteome Res. 2010, 9, 308-318.
20. Parkin, D. M., Bray, F., Ferlay, J., Pisani, P., Global cancer statistics 2002. CA Cancer J. Clin. 2005, 55, 74-108.
21. Lee, H. J., Kwon, M. S., Lee, E. Y., Cho, S. Y., Paik, Y. K., Establishment of a PF2D-MS/MS platform for rapid profiling and semiquantitative analysis of membrane protein biomarkers. Proteomics 2008, 8, 2168-2177.
22. Cho, S. Y., Lee, E. Y., Lee, J. S., Kim, H. Y. et al., Efficient prefractionation of low-abundance proteins in human plasma and construction of a two-dimensional map. Proteomics 2005, 5, 3386-3396.
23. Lee, H. J., Na, K., Kwon, M. S., Kim, H. et al., Quantitative analysis of phosphopeptides in search of the disease biomarker from the hepatocellular carcinoma specimen. Proteomics 2009, 9, 3395-3408.
24. Kennedy, J., Yi, E. C., Use of gas-phase fractionation to increase protein identifications: application to the peroxisome. Methods Mol. Biol. 2008, 432, 217-228.
25. Sun, W., Xing, B., Sun, Y., Du, X. et al., Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues. Mol. Cell. Proteomics. 2007, 6, 1798-1808.
26. Patel, V. J., Thalassinos, K., Slade, S. E., Connolly, J. B. et al., A comparison of labeling and label-free mass spectrometry-based proteomics approaches. J. Proteome Res. 2009, 8, 3752-3759.
27. Looi, K. S., Nakayasu, E. S., Diaz, R. A., Tan, E. M. et al., Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma. J. Proteome Res. 2008, 7, 4004-4012.
28. Dreger, M., Subcellular proteomics. Mass Spectrom. Rev. 2003, 22, 27-56.
29. Anderson, N. L., Anderson, N. G., The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 2002, 1, 845-867.
30. Hortin, G. L., Sviridov, D., Anderson, N. L., High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance. Clin. Chem. 2008, 54, 1608-1616.
31. Mardilovich, K., Pankratz, S. L., Shaw, L. M., Expression and function of the insulin receptor substrate proteins in cancer. Cell Commun. Signal. 2009, 7, 14.